Condition
Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
2Total
P 2 (2)
Trial Status
Terminated1
Completed1
Withdrawn1
Unknown1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04369989Terminated
Observational Study of COVID-19 Treatment Efficacy
NCT04332666Phase 2Unknown
Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial
NCT04459702Phase 2Withdrawn
A Study of Combination Therapies to Treat COVID-19 Infection
NCT04339387Completed
COVID-19 Risk Stratification
Showing all 4 trials